Market Tracker

12/05 3:41pm ET
1.97
BATS BZX Real-Time Price
As of 3:39pm ET
 +0.09 / +4.79%
Today’s Change
1.51
Today|||52-Week Range
14.10
-85.48%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close1.88
Today’s open1.91
Day’s range1.89 - 2.02
Volume42,329
Average volume (3 months)1,273,863
Market cap$164.1M
Dividend yield--
Data as of 3:39pm ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)-135.21%
Earnings growth (this year)-1.21%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-29.86%
P/E ratioNM
Price/Sales4.46
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVIVInVivo Therapeutics ...+0.08+1.56%
CBMGCellular Biomedicine...+0.30+2.37%
CYADCelyad SA0.000.00%
ENZYEnzymotec Ltd+0.10+1.59%
Data as of 3:41pm ET, 12/05/2016

Financials

Next reporting dateFebruary 3, 2017
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$60.0M
Annual profit (last year)-$144.8M
Net profit margin-241.35%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts